Production R & D
Product Search
I.Overview of production base
Located in the scenic Liuyang Economic and Technological Development Zone of the National Biomedical Industry Park, Hunan Weite Pharmaceutical Co., Ltd. occupy 66,666sqm with a registered capital of 10 million RMB. established since 2003, this integrated pharmaceutical enterprise combines production, sales, and R&D capabilities. A comprehensive pharmaceutical enterprise with a full range of API and preparations (tablets/capsules/granules). It is a "National High-tech Enterprise", “a intelligent manufacturing enterprise” in Changsha City, a "Little Giant Enterprise" in Hunan Province, and a "Little Giant" enterprise in Changsha City.
II. Products and production capacity
Two active pharmaceutical ingredient (API) production workshops, one oral solid dosage form workshop, and one traditional Chinese medicine extraction workshop. We hold 4 API production licenses and 21 oral solid dosage form production licenses. Annual production capacity includes 510 tons of APIs, 500 million tablets, 80 million capsules, and 20 million bags of granules.
The new intelligent comprehensive preparation workshop has almost been completed, It is expected to be put into production soon, and the annual total production capacity of oral solid preparation will be increased to 1.5 billion tablets.
III. Quality Management System and Certification (Quality & Compliance)
The company's tablets, hard capsules, granules, and active pharmaceutical ingredients (APIs) all have obtained GMP certification. The Quality Assurance (QA) Department is responsible for the establishment and continuous improvement of the quality management system, also responsible for ensuring quality control throughout the entire drug production process and can independently perform its duties. The Quality Control (QC) department currently operates nearly 100 modern analytical instruments, including 13 liquid chromatographs, 3 gas chromatographs, 1 liquid-gas chromatography-mass spectrometry (LC-MS), 1 Ion chromatography, 1 infrared spectrophotometer, 1 ultraviolet spectrophotometer, and 2 laser particle size analyzers. These instruments are equipped with audit-traceability features to ensure the accuracy of test data. A stringent quality control system has been established, strictly regulating all production stages—from raw materials and intermediates to finished products—to ensure compliance with quality standards.
IV. Technology and equipment advantages (Technology & Equipment)
Now the active pharmaceutical ingredients(APIs) are fully controlled by DCS , and the preparation is equipped with high efficiency wet granulation, fluid bed boiling drying, double discharge automatic high-speed tablet press, high-speed blister and automatic carton production line and other equipment, which can realize the whole process of automation control and ensure product quality.
V. Environmental, Safety and Sustainable Development (EHS & Sustainability)
The company has set up the safety and environmental protection department to be responsible for safety and waste treatment. Full-time safety officers have been equipped in the factory, and a set of safety standardization system has been established.
The sewage treatment system is established, with a sewage storage capacity of 2500m³, a daily treatment of 500m³ wastewater, and a COD treatment capacity of 5 tons/day;
The waste gas and noise meet the requirements of environmental protection, and the solid waste is entrusted to a professional qualification unit for treatment. The whole company adheres to the safety goal of "preventing risks, eliminating hidden dangers and preventing accidents" to protect the enterprise.
Contact Information
Manufacturing base address: No.97
Kangping Road, Economic Development Zone, Liuyang
Office address in Changsha: Floor 8, business building, Mawangdui Science and Technology Park, No. 948, Yuanda First Road, Changsha
1
